'Stonebridge-Backed' Medical AI Company Connective Selected as Next-Generation Unicorn Candidate at KPAS 2025
Recognized for Innovative AI-Based Medical Technology
Accelerating Expansion into the Global Healthcare Market
Connective, a medical artificial intelligence (AI) solutions company invested in by Stonebridge Ventures, has been selected as one of the 20 finalists for next-generation unicorn candidates in Korea at the 'KOREA Promising AI Startups 2025' (KPAS 2025), co-hosted by The Korea Economic Daily and KT. This selection recognizes Connective's innovation and growth potential based on its AI technology in the medical field.
KPAS 2025 is an AI startup discovery program that selects and nurtures 20 AI-based startups leading innovation across all industries. The awards ceremony, held in Seoul on October 16, was attended by Minister of Science and ICT Baek Kyunghoon, KT President Kim Youngseop, The Korea Economic Daily President Kim Joungho, Korea Venture Capital Association Chairman Kim Hakgyun, and Capstone Partners CEO Song Eungang.
Connective is developing a comprehensive digital solution for orthopedics by integrating AI imaging diagnostic software with robotic technology for artificial joint surgery. Its core products include: ▲ musculoskeletal X-ray diagnostic software, ▲ an AI surgical robot platform equipped with real-time 3D scanning and automatic alignment functions, and ▲ a cloud-based health data software-as-a-service (SaaS) for patient-specific analysis.
Based on its proprietary AI algorithms and 3D recognition technology, Connective is pursuing certifications in the United States, Europe, and Japan (CE, FDA, PMDA). The company has completed Korea’s Ministry of Food and Drug Safety review for 'HERO KNEE' and is supplying medical device 'CONNEVO Metric' to major domestic hospitals, contributing to improved patient satisfaction and increased revisit rates.
Hot Picks Today
"You Might Regret Not Buying Now"... Overseas Retail Investors Stirred by News of Record-Breaking Monster Stocks' IPOs
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Mistaken for the Flu, Left Untreated... Death Toll Surges as WHO Declares Emergency (Comprehensive)
- "Concerns Over Expanded Travel Rule"... FIU Holds Closed Meeting with Virtual Asset Industry on Enforcement Decree of the Act on Specified Financial Transaction Information
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Connective CEO Noh Dohyun stated, "We aim to become a global medtech leader by presenting a new paradigm in musculoskeletal medicine through the convergence of AI and robotics." Song Youngdon, Executive Director of Stonebridge Ventures who led the investment, commented, "Connective is a deep tech company providing total solutions from diagnosis to treatment in the high-growth musculoskeletal disease market, and we expect it to become a leading next-generation medical AI company."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
